Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Revivegen Co's Marketable Securities for the quarter that ended in Dec. 2025 was NT$12.4 Mil.
Revivegen Co's annual Marketable Securities
increased
from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$2.8 Mil) and
increased
from Dec. 2024 (NT$2.8 Mil) to Dec. 2025 (NT$12.4 Mil).
Revivegen Co (ROCO:7578) Marketable Securities Explanation
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
Revivegen Co Marketable Securities Related Terms
Revivegen Co Marketable Securities Historical Data
* Premium members only.
The historical data trend for Revivegen Co's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Marketable Securities of NT$12.4 Mil mean?
Revivegen Co (ROCO:7578) has a Marketable Securities of NT$12.4 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Revivegen Co and its competitors.
Is Revivegen Co's Marketable Securities too high?
Revivegen Co's current Marketable Securities is NT$12.4 Mil. Overall, Revivegen Co has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revivegen Co's Marketable Securities compare to WM and RSG?
Revivegen Co's Marketable Securities of NT$12.4 Mil can be compared against companies in the Waste Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Waste Management company?
A good Marketable Securities depends on the Waste Management industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Revivegen Co and its competitors. Revivegen Co's current Marketable Securities is NT$12.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revivegen Co stock overvalued right now?
Based on GuruFocus' analysis, Revivegen Co (ROCO:7578) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$30.64, compared to a current price of NT$25.80 — trading 15.8% below its estimated fair value. The current Marketable Securities is NT$12.4 Mil. Revivegen Co's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Revivegen Co (ROCO:7578), the current Marketable Securities is NT$12.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revivegen Co (ROCO:7578) Overvalued in 2026?
Based on GuruFocus' analysis, Revivegen Co stock appears to be undervalued.
The current stock price of NT$25.80 is trading 15.8% below its estimated GF Value™ of NT$30.64.
GuruFocus considers Revivegen Co to be Modestly Undervalued.
Key valuation signals for ROCO:7578:
Marketable Securities: NT$12.4 Mil
GF Value™: NT$30.64 vs. price of NT$25.80 (15.8% below fair value)
No single metric tells the full story. See the ROCO:7578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revivegen Co Ltd Formerly Revivegen Environmental Technology Co Ltd utilizes the waste solvent produced by electronics, optoelectronics, chemical industry, chemical industry and other industries to distill and recover the waste solvent in the physical treatment process (distillation) of the factory, and then produce recyclable solvent raw materials, which are recycled for industrial use.
50GF Score
Get the complete analysis for ROCO:7578
Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7578 has been successfully added to your 
